Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-six brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nineteen have assigned a buy rating to the company. […]
WP Advisors LLC reduced its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.7% during the third quarter, Holdings Channel reports. The fund owned 2,841 shares of the biopharmaceutical company’s stock after selling 20 shares during the period. Regeneron Pharmaceuticals comprises about 1.0% of WP Advisors LLC’s investment portfolio, making the […]
Keel Point LLC bought a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 264 shares of the biopharmaceutical company’s stock, valued at approximately $217,000. Several other hedge funds also recently modified their holdings […]
North Star Asset Management Inc. acquired a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 278 shares of the biopharmaceutical company’s stock, valued at approximately $229,000. A number of other institutional […]
Mcdonald Capital Investors Inc. CA reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 146,119 shares of the biopharmaceutical company’s stock after selling 3,080 […]